Drugmakers uninterested in Trump’s order to split up MMR vaccine
The reporting (4)
- Merck Stock (MRK): MMR Split Move Prolongs Cost Review, Delays Quick Revenue Gain TechStock² · 23d ago
- One Vaccine, Three Supply Chains: The Hidden Consequences of Splitting MMR Pharmaceutical Commerce · 23d ago
- Letters to the Editor Inquirer.com · 23d ago
- Drugmakers uninterested in Trump’s order to split up MMR vaccine The Hill · 23d ago broke it first
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
From around our network
Related trends
Nine-year-old boy in serious condition after infection caused by brain-eating amoeba
A nine-year-old boy is hospitalized in serious and critical condition after contracting a rare brain-eating amoeba.
7 new dementia risk factors revealed
Seven new dementia risk factors spark fresh public‑health push as millions remain unaware.
Opinion
Measles deaths rise, sparking petitions and calls for the health secretary’s resignation.
Scientists Find 'Ominous' Signs of Artery Damage in Nearly 8 in 10 Young Adults
A new guideline urges holistic care even as a study finds almost 8 in 10 young adults show early artery damage.
Nicotine vapes best chance to quit smoking, major review finds
A new major review crowns nicotine vapes the most effective tool for quitting smoking, sparking health‑policy debate.
Two die of measles in Pennsylvania outbreak, health officials say
Two unvaccinated Pennsylvanians die of measles as schools prepare to open, marking the nation’s first measles fatalities this year